Grant Budas Selected Research

Adenosine Triphosphate (ATP)

6/2006

Overexpression of SUR2A generates a cardiac phenotype resistant to ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Grant Budas Research Topics

Disease

3	Fibrosis (Cirrhosis) 01/2020 - 01/2008
2	Reperfusion Injury 10/2012 - 06/2006
1	Inflammation (Inflammations) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Osteoarthritis 01/2018
1	Rheumatoid Arthritis 01/2018
1	Myocardial Infarction 10/2012
1	Infarction (Infarctions) 10/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2012
1	Ischemia 01/2012
1	Cardiomegaly (Heart Hypertrophy) 01/2008
1	Atherosclerosis 01/2008
1	Heart Diseases (Heart Disease) 01/2008
1	Hypoxia (Hypoxemia) 06/2006

Drug/Important Bio-Agent (IBA)

3	MAP Kinase Kinase Kinase 5IBA 01/2020 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
1	GS-444217IBA 01/2020
1	NLR ProteinsIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	InflammasomesIBA 01/2020
1	ChloridesIBA 10/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2012
1	Caspase 3 (Caspase-3)IBA 10/2012
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	IsoenzymesIBA 01/2008
1	Protein Kinase CIBA 01/2008
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2008
1	Adenosine Triphosphate (ATP)IBA 06/2006

Therapy/Procedure

1	Therapeutics 01/2018